EX-23.1 3 d683457dex231.htm EX-23.1 EX-23.1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-205693, 333-209897, 333-216392, 333-223253 and 333-228263 on Form S-8, and Registration Statement Nos. 333-212793 and 333-225650 on Form S-3 of our report dated February 28, 2019, relating to the consolidated financial statements of Sierra Oncology, Inc. and subsidiaries (the “Company”) appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2018.

 

/s/ Deloitte & Touche LLP
Grand Rapids, Michigan
February 28, 2019